ONCY
USDOncolytics Biotech Inc. Common Shares
$0.965-0.135 (-12.282%)
Real-time Price
Healthcare
Biotechnology
Canada
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$1.100
High
$1.126
Low
$0.920
Volume
0.82M
Company Fundamentals
Market Cap
100.9M
Industry
Biotechnology
Country
Canada
Trading Stats
Avg Volume
1.02M
Exchange
NCM
Currency
USD
52-Week Range
Low $0.33Current $0.965High $1.51
Related News
BusinessWire
Oncolytics Biotech® Establishes Gastrointestinal Tumor Scientific Advisory Board to Advance Pelareorep as a Platform Immunotherapy
Initial members include Dr. Sanjay Goel (Rutgers), Dr. Deva Mahalingam (Northwestern), and Dr. Dirk Arnold (GOBLET study; Asklepios Tumorzentrum Hamburg) Scientific Advisory Board to guide registration strategy for
View more
PR Newswire
Oncolytics Biotech® Reports Updated Anal Cancer Data Showing Objective Response Rate More Than Double the Current Standard of Care
Oncolytics Biotech® Inc. (NASDAQ: ONCY) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing pelareorep, today...
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.